TCR2 Therapeutics Inc.

NASDAQ: TCRR · Real-Time Price · USD
1.48
0.00 (0.00%)
At close: May 31, 2023, 8:00 PM

TCR2 Therapeutics Revenue

TCR2 Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2023, TCR2 Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
58
Market Cap
58.11M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.